Company Filing History:
1 out of 1,373 
1 out of 1,209 
Years Active: 2014
Title: The Innovative Contributions of Andrew P. Weng
Introduction
Andrew P. Weng is an accomplished inventor based in Vancouver, Canada, known for his significant contributions to the field of molecular biology. With one patented invention, he has made strides in understanding receptor signaling, particularly through the NOTCH-1 receptor.
Latest Patents
His notable patent, titled "NOTCH mutations leading to increased receptor signaling," focuses on identifying specific regions within the NOTCH-1 receptor that, when mutated, can result in heightened receptor activity. These mutations are often linked to uncontrolled cellular growth, which plays a pivotal role in cancer development. The invention proposes that this aberrant growth could potentially be mitigated using inhibitors of gamma-secretase, providing a pathway for new cancer treatments. Furthermore, diagnostic assays for these NOTCH-1 mutations could become integral tools in the management and treatment of cancer patients.
Career Highlights
Andrew has held positions at esteemed institutions, notably The Brigham and Women's Hospital and Dana-Farber Cancer Institute. His work in these prestigious organizations showcases his dedication to advancing cancer research and patient care. Throughout his career, he has focused on the biological mechanisms of cancer, striving to develop innovative solutions to combat this challenging disease.
Collaborations
In his journey, Andrew has collaborated with fellow researchers, including Jon C. Aster and Stephen C. Blacklow. These partnerships underscore the collaborative spirit inherent in scientific innovation and the importance of teamwork in overcoming complex research challenges.
Conclusion
Andrew P. Weng's contributions to the understanding of NOTCH-1 receptor signaling represent a vital intersection of molecular biology and cancer therapeutics. His work not only enhances our comprehension of cellular growth regulation but also opens avenues for potential diagnostic and therapeutic interventions in cancer treatment. Through his patent and collaborations, he continues to make a meaningful impact in the field of medical research.